Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s dementia (THC-AD)

Please use this link to access this publication. Abstract Agitation is a common complication of Alzheimer’s dementia (Agit-AD) associated with substantial morbidity, high healthcare service

May 20, 2024

Study protocol of a pilot randomized controlled trial of transcranial direct current stimulation paired with reappraisal training for treatment of cannabis use disorder

Abstract Introduction As legalization of cannabis products continues, cannabis use becomes more prevalent, and concerns regarding cannabis use disorder (CUD) rise, improving CUD treatment has

March 1, 2026

Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia

Abstract Cannabidiol (CBD) exhibits anti-inflammatory and neuroprotective properties and is suggested to be effective in the pre-clinical and clinical treatment of illnesses of the central

April 16, 2024

Studies Investigating the Mechanisms of the Cardioprotective Effects of Cannabidiol

The phytocannabinoid cannabidiol (CBD) has a complex pharmacology which is thought to include, but is not limited to, an ability to act as an inverse

September 19, 2019

Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington’s disease transgenic mice

Loss of cannabinoid receptors (CB1) occurs prior to neurodegeneration in Huntington’s disease (HD). The levels and distribution of CB1 RNA were equivalent in 3-week-old mice

Structural MRI Findings in Long-Term Cannabis Users: What Do We Know?

Please use this link to access this publication. Abstract In animal studies, tetrahydrocannabinol (THC) has been found to affect brain morphology, particularly within areas rich

September 4, 2024

Structural connectivity in adolescent synthetic cannabinoid users with and without ADHD

Please use this link to access this publication. Abstract Synthetic cannabinoids (SC) have become increasingly popular in the last few years, especially among adolescents. Given

September 19, 2025

Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs

Abstract Nociception and motor coordination are critically governed by glycine receptor (GlyR) function at inhibitory synapses. Consequentially, GlyRs are attractive targets in the management of

February 23, 2024

Stigma, risks, and benefits of medicinal cannabis use among Australians with cancer

Please use this link to access this publication. Abstract Purpose: People with cancer who use medicinal cannabis do so despite risks associated with limited clinical evidence,

September 5, 2024

Stereoisomers of cannabidiols and their pharmacological activities – A potentially novel direction for cannabinoids

Abstract Cannabidiol (CBD), a bicyclic non-psychoactive cannabinoid biosynthesized by Cannabis spp. of plants, has attracted significant interest in the past decade due to its therapeutic properties. In 2018, the US

April 4, 2026